SHL Medical has revealed plans for a new manufacturing site in the U.S. in response to the growing market demand for its autoinjector product portfolio. The decision stems from SHL's strategic assessments in extending its production to North America.
The new U.S. site will be located in North Charleston, South Carolina, and will boast approximately 270,000 square feet. With initial investments of $90 million, SHL is expected to create an estimate of 165 local employment opportunities. Operations are expected to launch by 2024.
The South Carolina site will be an advanced facility with medical device injection molding and fully automated assembly capabilities. Together with SHL's current final assembly, labeling and packaging operations in Deerfield Beach, Florida, the expanded manufacturing capabilities in the U.S. will further fortify SHL's offerings in delivering comprehensive services to its partners.
In 2019, SHL developed a long-term strategy in response to the growing autoinjector demand and to meet future manufacturing needs. The announcement of the new U.S. operation aligns with the company's ongoing expansion, including a new Swiss site already being announced.
